SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-055976
Filing Date
2021-04-28
Accepted
2021-04-28 07:06:38
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm212517d2_defa14a.htm DEFA14A 20234
2 GRAPHIC tm212517d2_def14aimg01.gif GRAPHIC 105175
3 GRAPHIC tm212517d2_def14aimg02.gif GRAPHIC 101110
  Complete submission text file 0001104659-21-055976.txt   305606
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37990 | Film No.: 21861297
SIC: 2834 Pharmaceutical Preparations